AIP
IMA

Ameritas Investment Partners’s ImageneBio Inc IMA Stock Holding History

Ameritas Investment Partners’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-146
Closed -$2.49K – 3178
2024
Q1 		$2.49K Hold
146
– – ﹤0.01% 3020
2023
Q4 		$3.46K Hold
146
– – ﹤0.01% 3020
2023
Q3 		$7.6K Hold
146
– – ﹤0.01% 2905
2023
Q2 		$11.5K Buy
+146
New +$10.5K ﹤0.01% 2857
2022
Q2 		– Sell
-179
Closed -$13K – 3145
2022
Q1 		$13K Hold
179
– – ﹤0.01% 2710
2021
Q4 		$27K Buy
179
+120
+203% +$19.5K ﹤0.01% 2496
2021
Q3 		$9K Hold
59
– – ﹤0.01% 2962
2021
Q2 		$10K Buy
+59
New +$13K ﹤0.01% 2931

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameritas Investment Partners's IMA Position: Q2 2024 in Review

Ameritas Investment Partners sold out of ImageneBio Inc (IMA) in Q2 2024, closing a stake of 146 shares — an estimated $2.49K sold.

Ameritas Investment Partners first reported a position in IMA in Q2 2021 and held it in 8 quarters. The position peaked at $27K in Q4 2021. 70 funds tracked by Wall St. Rank hold IMA as of Q2 2024.

  • Ameritas Investment Partners reported no remaining ImageneBio Inc position as of Q2 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 146 ImageneBio Inc shares in Q2 2024, an estimated $2.49K.
  • Ameritas Investment Partners first reported a position in ImageneBio Inc in Q2 2021 and held it in 8 quarters.
  • Ameritas Investment Partners's ImageneBio Inc position peaked at $27K in Q4 2021.
  • 70 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.